Louisiana State Employees Retirement System Sells 300 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Louisiana State Employees Retirement System cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,300 shares of the company’s stock after selling 300 shares during the period. Louisiana State Employees Retirement System’s holdings in U.S. Physical Therapy were worth $618,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of USPH. Norden Group LLC raised its stake in shares of U.S. Physical Therapy by 37.5% during the first quarter. Norden Group LLC now owns 4,528 shares of the company’s stock valued at $511,000 after acquiring an additional 1,235 shares during the last quarter. BNP Paribas Financial Markets raised its stake in shares of U.S. Physical Therapy by 6.8% during the first quarter. BNP Paribas Financial Markets now owns 7,837 shares of the company’s stock valued at $885,000 after acquiring an additional 502 shares during the last quarter. GSA Capital Partners LLP raised its stake in shares of U.S. Physical Therapy by 110.3% during the first quarter. GSA Capital Partners LLP now owns 7,909 shares of the company’s stock valued at $893,000 after acquiring an additional 4,149 shares during the last quarter. Texas Permanent School Fund Corp raised its stake in shares of U.S. Physical Therapy by 1.3% during the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after acquiring an additional 170 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. bought a new position in shares of U.S. Physical Therapy during the first quarter valued at about $391,000.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the acquisition, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Price Performance

USPH stock opened at $82.50 on Wednesday. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a market cap of $1.24 billion, a P/E ratio of 78.26, a PEG ratio of 3.86 and a beta of 1.38. The firm has a 50-day moving average of $82.94 and a 200 day moving average of $91.61. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. U.S. Physical Therapy’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.76 EPS. On average, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 2.13%. The ex-dividend date of this dividend was Friday, August 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 166.04%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on USPH shares. Bank of America reaffirmed a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Wednesday, October 9th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.